mTORC1 Signaling Can Regulate Growth Factor Activation of p44/42 Mitogen-activated Protein Kinases through Protein Phosphatase 2A
Franklin C. Harwood(St. Jude Children's Research Hospital), Peter J. Houghton(The University of Texas at San Antonio Health Science Center)
Cited by 25
Related Papers
The pediatric preclinical testing program: Description of models and early testing results
|Pediatric Blood & Cancer|2006|486
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.
|PubMed|1996|388
Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.
|PubMed|2003|198
ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer
|Science Advances|2018|135
Predominant Nuclear Localization of Mammalian Target of Rapamycin in Normal and Malignant Cells in Culture
|Journal of Biological Chemistry|2002|127